How should a 10-year-old child presenting with cough and wheeze be evaluated and managed?

Evaluation and Management of a 10-Year-Old with Cough and Wheeze

This child most likely has asthma and should immediately receive salbutamol via metered-dose inhaler (MDI) with a large-volume spacer (2–20 puffs depending on severity), followed by oral prednisolone 1–2 mg/kg if symptoms are severe, while simultaneously verifying proper inhaler technique and initiating low-dose inhaled corticosteroids (≤400 µg/day beclomethasone-equivalent) for ongoing control. 1, 2

Immediate Assessment and Initial Management

First-Line Bronchodilator Therapy

• Administer salbutamol immediately using an MDI with large-volume spacer (100 µg per actuation, 2–20 puffs based on severity) rather than a nebulizer, as spacers deliver medication more efficiently and nebulizers are overused in this age group. 1, 2
• Re-evaluate respiratory rate, work of breathing, heart rate, and wheeze after 15–30 minutes to assess response. 1
• If symptoms persist or worsen, repeat salbutamol every 4 hours initially, escalating to every 30 minutes if no improvement occurs. 1, 2

Systemic Corticosteroids for Severe Presentations

• Start oral prednisolone 1–2 mg/kg once daily (maximum 40 mg) without delay if the child has severe symptoms, significant work of breathing, or poor initial response to bronchodilators. 1
• A 3–5 day course is sufficient for most acute exacerbations. 1

Critical Technique Verification

• Before escalating therapy, verify proper inhaler technique—this is the most common reason for treatment failure in pediatric asthma. 1, 2
• At age 10, the child should use either an MDI with large-volume spacer or a dry-powder inhaler if adequate technique can be demonstrated; unmodified MDIs without spacers should never be prescribed. 1, 2
• Correct spacer technique: actuate the MDI, inhale one puff, re-actuate, inhale the next puff, continuing until the prescribed number is completed. 2

Diagnostic Evaluation

Essential Workup

• Obtain spirometry with pre- and post-bronchodilator measurements to confirm reversible airway obstruction, which is the hallmark of asthma. 1
• Order a chest radiograph to exclude pneumonia, foreign body aspiration, or structural abnormalities—normal vital signs do not rule out serious pathology. 1
• Recognize that absence of wheeze on examination does not exclude asthma; recurrent cough, especially nocturnal cough, is a recognized asthma manifestation in children. 2, 3

Targeted Testing Based on Clinical Features

• Consider pertussis PCR if paroxysmal cough with post-tussive vomiting is present. 1
• Perform airway hyper-responsiveness testing if spirometry is inconclusive. 1
• Evaluate for tuberculosis if exposure history exists. 1
• Rule out gastro-oesophageal reflux, cystic fibrosis, or chronic aspiration if atypical features are present. 4, 5

Controller Therapy Initiation

Inhaled Corticosteroids as Cornerstone

• For confirmed asthma, initiate low-dose inhaled corticosteroids (≤400 µg/day beclomethasone-equivalent) as the mainstay of preventive treatment, combining effectiveness with relative freedom from side effects and the convenience of twice-daily dosing. 4, 1, 2
• Every child using an MDI for inhaled steroids must use a large-volume spacer to enhance lung deposition and minimize systemic absorption. 4, 1, 2
• Use the lowest dose that provides acceptable control; there is no convincing evidence of important differences between currently available inhaled steroid preparations. 4

Reassessment and Diagnosis Confirmation

• Reassess response after 2–4 weeks; if no clinical benefit occurs, discontinue the medication and reconsider the diagnosis. 1, 2
• Treatment should be etiology-driven; empirical simultaneous therapy for multiple conditions (upper-airway cough syndrome, GERD, asthma) is discouraged unless specific features are identified. 1
• Isolated chronic cough in children is rarely asthma, and the term "cough variant asthma" should be used cautiously—only after demonstrating variable airflow obstruction and clear response to therapy. 6, 3

Adjunctive Therapy and Escalation

When Initial Bronchodilator Fails

• Add ipratropium bromide 250 µg to the nebulizer if no improvement occurs after the initial salbutamol dose, repeating every 6 hours. 1
• Frequent salbutamol use signals poor control and necessitates prompt initiation or optimization of controller therapy rather than increasing bronchodilator frequency. 2

Admission Criteria

• Admit to hospital if no improvement or deterioration occurs despite initial therapy, increasing bronchodilator frequency to every 30 minutes while maintaining oxygen and systemic steroids. 1
• Investigate alternative diagnoses such as foreign-body aspiration or pneumonia in non-responders. 1

Long-Term Management and Education

Treatment Goals

• Aim for minimal daytime symptoms, no nocturnal awakenings, full participation in activities and sports, and infrequent reliever medication use. 4, 2
• Asthma itself delays growth and puberty, but eventual catch-up growth occurs; short-term reductions in tibial growth rate have been shown with inhaled steroids >400 µg/day, but these cannot be extrapolated to long-term effects. 4

Self-Management Plan Components

• Provide both oral and written instructions covering correct inhaler use, signs requiring urgent medical help, and environmental trigger avoidance. 4, 2
• Educate caregivers on the distinction between "relievers" (bronchodilators like salbutamol) and "preventers" (anti-inflammatory agents like inhaled corticosteroids). 4, 2
• Supply a peak-flow meter for home monitoring of lung function and include monitoring of symptoms, peak flow, and drug usage in the written action plan. 4, 1

Environmental Control

• Emphasize avoiding cigarette-smoke exposure and other known asthma triggers, as environmental factors—particularly tobacco smoke—are critical modifiable risk factors. 1, 2, 6

Common Pitfalls to Avoid

• Do not routinely use nebulizers; they are more costly, time-consuming, and less efficient than an MDI with spacer in this age group. 1, 2
• Never prescribe an unmodified MDI without a spacer to a 10-year-old child. 1, 2
• Failure to assess and correct inhaler technique is the most common reason for treatment failure—always verify before escalating therapy. 1, 2
• Delay in reassessing a child requiring frequent salbutamol indicates suboptimal control and should prompt controller therapy initiation. 2
• Over-the-counter cough remedies (anti-tussives, mucolytics, antihistamines) have no scientific evidence supporting their use and may have serious side effects—they should not be prescribed. 7, 6